Autor/es reacciones

Manel Juan

Head of the Immunology Service

The press release does outline the study. It is a very relevant study on the diagnostic potential of the analysis by artificial intelligence (machine learning) of the sequences of specific lymphocyte receptors (TcR and BcR) to decipher the history of past infections and diseases of an individual's immune system. This seems to provide a very powerful tool for diagnosing autoimmune disorders, viral infections, vaccine responses, and, in general, all diseases where the immune response plays a role, which is practically all of them. The study is well documented and the conclusions will need more specific studies, but the data are very indicative that the options for the future are very high. The main limitation comes from the implementation of massive sequencing methods for the continuous diagnosis of pathological situations, which is still a technical and economic challenge in most healthcare settings. The proposal can certainly have diagnostic and patient management implications in the real world, although it needs to be ‘grounded’ in more specific cases.

EN